Ally Bridge Group »

An2 Therapeutics shares owned by Ally Bridge Group

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.8M 526k 3.42

More positions owned by Ally Bridge Group

Soleno Therapeutics (SLNO)
Praxis Precision Medicines I Com New (PRAX)
Minerva Neurosciences Com New (NERV)
Ovid Therapeutics (OVID)
Compass Pathways Sponsored Ads (CMPS)
Tarsus Pharmaceuticals (TARS)
Solid Biosciences Com New (SLDB)
Compass Therapeutics Call Option (CMPX)
Promis Neurosciences Com Shs (PMN)
Edgewise Therapeutics (EWTX)
Uniqure Nv SHS Call Option (QURE)
Eupraxia Pharmaceuticals (EPRX)
Cytomx Therapeutics (CTMX)
Inventiva Sa Ads (IVA)
Perspective Therapeutics Com New (CATX)

View all positions for Ally Bridge Group

Top funds holding An2 Therapeutics

Vivo Capital
Commodore Capital
Millennium Management
Almitas Capital
Vanguard Group
Vanguard Capital Management
Woodline Partners
Ameriprise Financial
Stonepine Capital Management
Ally Bridge Group
Bank of Nova Scotia
Bank of America Corporation
Renaissance Technologies
BlackRock
Jane Street

View all funds holding An2 Therapeutics